The PPI network suggested that proteins coexpressed with EPC1 might be involved in various cancer-related signaling pathways, such as HPV infection, endocrine resistance, cell cycle disruption, plaque adhesion, breast cancer, gastric cancer, hepatocellular carcinoma, pancreatic cancer, and small-cell lung cancer. Here, EPC1 is linked to familial pancreatic carcinoma.